Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 2008

View Archived Issues

Amitriptyline beneficial in benign prostatic hyperplasia

AstraZeneca develops 5-HT1B receptor radioligand for PET imaging

Notch inhibition with MRK-003 active in preclinical pancreatic cancer experiments

Recent GSK, Pfizer and Roche patents disclose new antipsychotic agents

Novel therapeutic agents for respiratory and allergic disorders described in recent patents

Recent Bayer and Takeda patents disclose novel compounds for cardiovascular disorders

Snapshots: Recent data on immunoconjugates from ImmunoGen

Interim results from a phase I solid tumor study with weekly EZN-2968

GlaxoSmithKline: Q3 review

FDA accepts IND for ART-621, Arana to commence phase II studies

PAION reports successful meta-analysis for pain drug M6G

Synosia starts phase IIa nepicastat trial in post-traumatic stress disorder

TMC-207 shows promise as a treatment for tuberculosis

FDA approves donated blood screening test for HIV, HCV and HBV

FDA approves Treanda for relapsed indolent non-Hodgkin's lymphoma

Mpex initiates phase II clinical trial of aerosol MP-376 in COPD

Neoprobe receives positive EMEA response to RIGScan CR submission

ProStrakan launches Sancuso in U.S. for chemotherapy-induced nausea

Welichem reports phase IIa results for WBI-1001 atopic dermatitis cream

BioMarin commences clinical assessment program for Morquio A syndrome

MedImmune commences phase I/IIa trial for respiratory syncytial virus vaccine

Portola starts phase II betrixaban trial for stroke prevention in atrial fibrillation

Medarex and MBL report results from phase II trial of MDX-066 and MDX-1388

AEterna Zentaris initiates second stage of patient recruitment in phase II trial of AEZS-108

Canopus reports results from specialized laboratory study of peptide cancer vaccine

Cel-Sci expands licensing agreement for cancer drug Multikine to Orient Europharma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...